Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
BMJ
; 344: d7373, 2012 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-22214756
ABSTRACT
OBJECTIVE:
To examine compliance with mandatory reporting of summary clinical trial results (within one year of completion of trial) on ClinicalTrials.gov for studies that fall under the recent Food and Drug Administration Amendments Act (FDAAA) legislation.DESIGN:
Registry based study of clinical trial summaries. DATA SOURCES ClinicalTrials.gov, searched on 19 January 2011, with cross referencing with Drugs@FDA to determine for which trials mandatory reporting was required within one year. Selection criteria Studies registered on ClinicalTrials.gov with US sites which completed between 1 January and 31 December 2009. MAIN OUTCOMEMEASURE:
Proportion of trials for which results had been reported.RESULTS:
The ClinicalTrials.gov registry contained 83,579 entries for interventional trials, of which 5642 were completed within the timescale of interest. We identified trials as falling within the mandatory reporting rules if they were covered by the FDAAA (trials of a drug, device, or biological agent, which have at least one US site, and are of phase II or later) and if they investigated a drug that already had approval from the Food and Drug Administration. Of these, 163/738 (22%) had reported results within one year of completion of the trial compared with 76/727 (10%) trials that were not subject to mandatory reporting (95% confidence interval for the difference in proportions 7.8% to 15.5%; χ(2) test, P = 2.6 × 10(-9)). Later phase trials were more likely to report results (P = 4.4 × 10(-11)), as were industry funded trials (P = 2.2 × 10(-16)).CONCLUSION:
Most trials subject to mandatory reporting did not report results within a year of completion.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Registries
/
Clinical Trials as Topic
/
Databases, Factual
/
Disclosure
Type of study:
Clinical_trials
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
America do norte
Language:
En
Journal:
BMJ
Journal subject:
MEDICINA
Year:
2012
Document type:
Article
Affiliation country:
United kingdom